Reinsurance Gr (NYSE:RGA) Bolsa

REINSURANCE GROUP OF AMERICA

Reinsurance Gr

Reinsurance Group of America Inc is an insurance holding company with operations in the United States, Latin America, Canada, Europe, Africa, Asia, and Australia. The core products and services include life reinsurance, living benefits reinsurance, group reinsurance, health reinsurance, financial solutions, facultative underwriting, and product development. The company's operations are divided into traditional and financial solution businesses.

Reinsurance Group of America, Incorporated Common Stock

Reinsurance Group of America Inc

RIGAKU HOLDINGS CORP by RIGAKU HOLDINGS CORP.

Wells Fargo analyst Elyse Greenspan maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Overweight and raises the price target from $248 to $249.

News

Price Target

Analyst Ratings

Wells Fargo Maintains Overweight on Reinsurance Gr, Raises Price Target to $249

Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) has outperformed the market over the past 5 years by 7.53% on an annualized basis producing an average annual return of 21.9%. Currently, Reinsurance Gr has a market capitalization of $12.91 billion. 
Buying $100 In RGA: If an investor had bought $100 of RGA stock 5 years ago, it would be worth $275.20 today based on a price of $195.28 for RGA at the time of writing.
<h3>Reinsurance Gr's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752103813_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much You Would Have Made Owning Reinsurance Gr Stock In The Last 5 Years

JP Morgan analyst Jimmy Bhullar maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Overweight and raises the price target from $237 to $264.

JP Morgan Maintains Overweight on Reinsurance Gr, Raises Price Target to $264

Reinsurance Gr's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) short percent of float has fallen 15.06% since its last report. The company recently reported that it has 431 thousand shares sold short, which is 4.68% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.1 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Reinsurance Gr Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749751219_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Reinsurance Gr has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Reinsurance Gr's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Reinsurance Gr's peer group average for short interest as a percentage of float is 2.10%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Reinsurance Gr?

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>HC Wainwright &amp; Co. analyst Mitchell Kapoor upgraded Kyverna Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KYTX#NASDAQ">KYTX</a>) from Neutral to Buy and raised the price target from $4 to $5. Kyverna Therapeutics shares closed at $2.27 on Friday. <a href="https://www.benzinga.com/quote/kytx/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wolfe Research analyst Timna Tanners upgraded the rating for Commercial Metals Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMC#NYSE">CMC</a>) from Peer Perform to Outperform. Commercial Metals shares closed at $46.13 on Friday. <a href="https://www.benzinga.com/quote/cmc/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>DA Davidson analyst Brian Holland upgraded BellRing Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRBR#NYSE">BRBR</a>) from Neutral to Buy and announced&nbsp;a price target of $85. BellRing Brands shares closed at $61.68 on Friday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Patrick Baumann upgraded MSC Industrial Direct Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSM#NYSE">MSM</a>) from Neutral to Overweight and raised the price target from $73 to $89. MSC Industrial Direct shares closed at $78.68 on Friday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst Kevin Caliendo upgraded LifeStance Health Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFST#NASDAQ">LFST</a>) from Neutral to Buy and announced a price target of $8.5. LifeStance Health shares closed at $5.49 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying CMC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="580" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/27080829/image-337-1024x580.png" alt="" class="wp-image-928243" style="width:642px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/27080829/image-337-1024x580.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/27080829/image-337-300x170.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/27080829/image-337-768x435.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/27080829/image-337.png 1108w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45585696/how-to-earn-500-a-month-from-dicks-sporting-goods-stock-ahead-of-q1-earnings">How To Earn $500 A Month From Dick&#8217;s Sporting Goods Stock Ahead Of Q1 Earnings</a> </li>
</ul>
Photo via Shutterstock

Upgrades

Pre-Market Outlook

Markets

BRBR

CTOR

GMED

KYTX

LFST

This Commercial Metals Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

During the last three months, 9 analysts shared their evaluations of Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>), revealing diverse outlooks from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">7</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $243.89, with a high estimate of $270.00 and a low estimate of $209.00. This current average represents a 2.66% decrease from the previous average price target of $250.56. 
<img src="https://www.benzinga.com/files/images/story/2025/1748030447_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The analysis of recent analyst actions sheds light on the perception of Reinsurance Gr by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Nigel Dally</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$209.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>Ryan Krueger</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$255.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$248.00</td>
<td>$246.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$246.00</td>
<td>$264.00</td>
</tr>
<tr>
<td>Ryan Krueger</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$250.00</td>
<td>$275.00</td>
</tr>
<tr>
<td>Brian Meredith</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$216.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$237.00</td>
<td>$232.00</td>
</tr>
<tr>
<td>Thomas Gallagher</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$270.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$264.00</td>
<td>$263.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Reinsurance Gr. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Reinsurance Gr compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Reinsurance Gr's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Reinsurance Gr's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/RGA/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Reinsurance Gr analyst ratings.</a>
<h2>Get to Know Reinsurance Gr Better</h2>
Reinsurance Group of America Inc is an insurance holding company with operations in the United States, Latin America, Canada, Europe, Africa, Asia, and Australia. The core products and services include life reinsurance, living benefits reinsurance, group reinsurance, health reinsurance, financial solutions, facultative underwriting, and product development. The company's operations are divided into traditional and financial solution businesses.
<h3>Reinsurance Gr: A Financial Overview</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: Reinsurance Gr's revenue growth over a period of 3M has faced challenges. As of 31 March, 2025, the company experienced a revenue decline of approximately -16.67%. This indicates a decrease in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 5.42%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Reinsurance Gr's ROE stands out, surpassing industry averages. With an impressive ROE of 2.57%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Reinsurance Gr's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.23%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a below-average debt-to-equity ratio of 0.5, Reinsurance Gr adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>What Are Analyst Ratings?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On Reinsurance Gr Through 9 Analysts

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Keybanc analyst Ashley Owens downgraded the rating for Deckers Outdoor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) from Overweight to Sector Weight. Deckers Outdoor shares closed at $126.09 on Thursday. <a href="https://www.benzinga.com/quote/deck/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Compass Point analyst Giuliano Bologna downgraded Radian Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDN#NYSE">RDN</a>) from Buy to Neutral but raised the price target from $34 to $37. Radian Group shares closed at $33.66 on Thursday. <a href="https://www.benzinga.com/quote/rdn/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Maxim Group analyst Jason McCarthy downgraded the rating for Citius Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTXR#NASDAQ">CTXR</a>) from Buy to Hold. Citius Pharmaceuticals shares closed at $0.7240 on Thursday. <a href="https://www.benzinga.com/quote/ctxr/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Raymond James analyst Wilma Burdis downgraded Reinsurance Group of America, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) from Strong Buy to Market Perform. Reinsurance Group shares closed at $202.89 on Thursday. <a href="https://www.benzinga.com/quote/rga/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Maxim Group analyst Michael Okunewitch downgraded Citius Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTOR#NASDAQ">CTOR</a>) from Buy to Hold. Citius Oncology shares closed at $0.9090 on Thursday. <a href="https://www.benzinga.com/quote/ctor/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying DECK stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="568" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23113954/image-310-1024x568.png" alt="" class="wp-image-926310" style="width:606px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23113954/image-310-1024x568.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23113954/image-310-300x166.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23113954/image-310-768x426.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23113954/image-310.png 1113w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45585296/jim-cramer-says-medical-properties-trust-has-too-much-risk-likes-this-industrial-stock">Jim Cramer Says Medical Properties Trust Has &#8216;Too Much Risk,&#8217; Likes This Industrial Stock</a> </li>
</ul>
Photo via Shutterstock

Downgrades

CTXR

DECK

This Deckers Outdoor Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Raymond James analyst Wilma Burdis downgrades Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) from Strong Buy to Market Perform.

Raymond James Downgrades Reinsurance Gr to Market Perform

Morgan Stanley analyst Nigel Dally maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Equal-Weight and raises the price target from $195 to $209.

Morgan Stanley Maintains Equal-Weight on Reinsurance Gr, Raises Price Target to $209

Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) has outperformed the market over the past 5 years by 3.46% on an annualized basis producing an average annual return of 18.11%. Currently, Reinsurance Gr has a market capitalization of $13.73 billion. 
Buying $1000 In RGA: If an investor had bought $1000 of RGA stock 5 years ago, it would be worth $2,502.53 today based on a price of $207.73 for RGA at the time of writing.
<h3>Reinsurance Gr's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747144817_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

Keefe, Bruyette &amp; Woods analyst Ryan Krueger maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Outperform and raises the price target from $250 to $255.

Keefe, Bruyette & Woods Maintains Outperform on Reinsurance Gr, Raises Price Target to $255

Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) has outperformed the market over the past 5 years by 2.76% on an annualized basis producing an average annual return of 16.59%. Currently, Reinsurance Gr has a market capitalization of $13.10 billion. 
Buying $1000 In RGA: If an investor had bought $1000 of RGA stock 5 years ago, it would be worth $2,085.99 today based on a price of $198.19 for RGA at the time of writing.
<h3>Reinsurance Gr's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746571524_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analysts' ratings for Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) over the last quarter vary from bullish to bearish, as provided by 11 analysts.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">9</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Reinsurance Gr and provided 12-month price targets. The average target is $246.73, accompanied by a high estimate of $270.00 and a low estimate of $216.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 2.93%. 
<img src="https://www.benzinga.com/files/images/story/2025/1746565234_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The standing of Reinsurance Gr among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$248.00</td>
<td>$246.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$246.00</td>
<td>$264.00</td>
</tr>
<tr>
<td>Ryan Krueger</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$250.00</td>
<td>$275.00</td>
</tr>
<tr>
<td>Brian Meredith</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$216.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$237.00</td>
<td>$232.00</td>
</tr>
<tr>
<td>Thomas Gallagher</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$270.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$264.00</td>
<td>$263.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$263.00</td>
<td>$244.00</td>
</tr>
<tr>
<td>Nigel Dally</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$233.00</td>
<td>$245.00</td>
</tr>
<tr>
<td>Scott Heleniak</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$245.00</td>
<td>$245.00</td>
</tr>
<tr>
<td>John Barnidge</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$242.00</td>
<td>$252.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Reinsurance Gr. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Reinsurance Gr compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Reinsurance Gr's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Reinsurance Gr's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/RGA/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Reinsurance Gr analyst ratings.</a>
<h2>About Reinsurance Gr</h2>
Reinsurance Group of America Inc is an insurance holding company with operations in the United States, Latin America, Canada, Europe, Africa, Asia, and Australia. The core products and services include life reinsurance, living benefits reinsurance, group reinsurance, health reinsurance, financial solutions, facultative underwriting, and product development. The company's operations are divided into traditional and financial solution businesses.
<h3>Reinsurance Gr's Financial Performance</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Negative Revenue Trend: Examining Reinsurance Gr's financials over 3M reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately -16.67% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Reinsurance Gr's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.42% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 2.57%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Reinsurance Gr's ROA stands out, surpassing industry averages. With an impressive ROA of 0.23%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Reinsurance Gr's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.5.
<h2>Analyst Ratings: Simplified</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

11 Analysts Have This To Say About Reinsurance Gr

Wells Fargo analyst Elyse Greenspan maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Overweight and raises the price target from $246 to $248.

Wells Fargo Maintains Overweight on Reinsurance Gr, Raises Price Target to $248

WIIM

ACGL

ALLY

ARES

ERIE

FINV

FUTU

HOOD

IBKR

KNSL

LMND

LPLA

MOGO

MORN

NTRS

PLMR

QFIN

SPNT

STEC

STEP

TROW

UPST

Shares of companies within the broader financial sector are trading higher amid overall market strength following April's jobs data and reports that China's Commerce Ministry is assessing possible trade talks with the US.

Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) reported quarterly earnings of $5.66 per share which beat the analyst consensus estimate of $5.32 by 6.39 percent. This is a 5.98 percent decrease over earnings of $6.02 per share from the same period last year. The company reported quarterly sales of $5.26 billion which missed the analyst consensus estimate of $5.68 billion by 7.45 percent. This is a 17.00 percent decrease over sales of $6.34 billion the same period last year.

Earnings

Earnings Beats

Earnings Misses

Reinsurance Gr Q1 Adj. EPS $5.66 Beats $5.32 Estimate, Sales $5.26B Miss $5.68B Estimate

AAMI

AAPL

ABNB

ACCO

ADPT

AGCO

AGIO

ALHC

ALKS

ALNY

ALSN

AMGN

AMWL

AMZN

APLE

APTV

ARDX

ARVN

ASND

ASPS

ASUR

ATEC

ATEN

AXTI

BBAI

BIIB

BJRI

BLDR

BMRN

BOOM

BPMC

BRFH

CABO

CARR

CART

CERS

CMLS

COHN

COHU

COLM

COMM

COOK

CRAI

CTRE

CUBE

CWST

DBRG

DINO

DSGR

DUOL

DXCM

ECVT

ELME

Earnings Scheduled For May 1, 2025

Wells Fargo analyst Elyse Greenspan maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Overweight and lowers the price target from $264 to $246.

Wells Fargo Maintains Overweight on Reinsurance Gr, Lowers Price Target to $246

CRBG

ENVA

FRHC

HLNE

Janus Henderson Group plc Ordinary Shares

PIPR

SNEX

SPGI

VCTR

Shares of companies within the broader financial sector are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

Keefe, Bruyette &amp; Woods analyst Ryan Krueger maintains Reinsurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>) with a Outperform and lowers the price target from $275 to $250.

Keefe, Bruyette & Woods Maintains Outperform on Reinsurance Gr, Lowers Price Target to $250

Press Releases

Reinsurance Group of America Reports Fourth Quarter and Full Year Results

RGA Announces Reinsurance Transaction with Equitable Holdings

Reinsurance Group of America Announces Pricing of Subordinated Debentures

Reinsurance Group of America Announces First Quarter Earnings Release Date, Webcast

RGA Appoints My Chi To as Executive Vice President, Chief Legal Officer, and Corporate Secretary

Reinsurance Group of America Reports First Quarter Results

JAB Insurance Names Jin Chang as Partner

Reinsurance Group of America Ranked #196 on the 2025 Fortune 500 List

IIS Announces RGA Leaders of Tomorrow Class of 2025, Set to Feature Participants at the Global Insurance Forum

Reinsurance Group of America Announces Second Quarter Earnings Release Date, Webcast

Comments

Reinsurance Gr

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL